https://www.selleckchem.com/pr....oducts/nazartinib-eg
39; 95% CI 0.50-0.97) and psychological (OR = 1.37; 95% CI 1.01-1.93) domains. In city patients, we observed a relationship between the drug and Qol in the physical (1/OR = 1.25; 95% CI 0.62-0.98) and psychological (OR = 1.49; 95% CI 1.13) domains. Younger patients living in a rural area with a lower assessment of met needs, a higher level of QoL in physical and environmental domains, and a lower social domain, as well as patients living in a city with a lower QoL in the physical domain and a higher psychological domai